1PXV image
Deposition Date 2003-07-07
Release Date 2003-10-21
Last Version Date 2023-08-16
Entry Detail
PDB ID:
1PXV
Keywords:
Title:
The staphostatin-staphopain complex: a forward binding inhibitor in complex with its target cysteine protease
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.80 Å
R-Value Free:
0.22
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
P 21 21 21
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:cysteine protease
Mutagens:C243A
Chain IDs:A, B
Chain Length:183
Number of Molecules:2
Biological Source:Staphylococcus aureus
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:cysteine protease Inhibitor
Gene (Uniprot):sspC
Chain IDs:C, D
Chain Length:111
Number of Molecules:2
Biological Source:Staphylococcus aureus
Primary Citation
The Staphostatin-Staphopain Complex: A FORWARD BINDING INHIBITOR IN COMPLEX WITH ITS TARGET CYSTEINE PROTEASE.
J.Biol.Chem. 278 40959 40966 (2003)
PMID: 12874290 DOI: 10.1074/jbc.M302926200

Abstact

Staphostatins are the endogenous inhibitors of the major secreted cysteine proteases of Staphylococcus aureus, the staphopains. Our recent crystal structure of staphostatin B has shown that this inhibitor forms a mixed, eight-stranded beta-barrel with statistically significant similarity to lipocalins, but not to cystatins. We now present the 1.8-A crystal structure of staphostatin B in complex with an inactive mutant of its target protease. The complex is held together through extensive interactions and buries a total surface area of 2300 A2. Unexpectedly for a cysteine protease inhibitor, staphostatin B binds to staphopain B in an almost substrate-like manner. The inhibitor polypeptide chain runs through the protease active site cleft in the forward direction, with residues IG-TS in P2 to P2' positions. Both in the free and complexed forms, the P1 glycine residue of the inhibitor is in a main chain conformation only accessible to glycines. Mutations in this residue lead to a loss of affinity of the inhibitor for protease and convert the inhibitor into a substrate.

Legend

Protein

Chemical

Disease

Primary Citation of related structures